Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses.

Journal of biomedicine & biotechnology

Ye L, Wen Z, Dong K, Pan L, Bu Z, Compans RW, Zhang H, Yang C.
PMID: 20508832
J Biomed Biotechnol. 2010;2010:497219. doi: 10.1155/2010/497219. Epub 2010 May 25.

The immune response induced by immunization with HIV Env DNA and virus-like particle (VLP) vaccines was investigated. Immunization with the HIV Env DNA vaccine induced a strong CD8 T cell response but relatively weak antibody response against the HIV...

Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles.

Procedia in vaccinology

Kim YC, Quan FS, Song JM, Vunnava A, Yoo DG, Park KM, Compans RW, Kang SM, Prausnitz MR.
PMID: 21528098
Procedia Vaccinol. 2010;2(1):15-19. doi: 10.1016/j.provac.2010.03.004.

Morbidity and mortality due to seasonal and pandemic influenza could be reduced by simpler vaccination methods that enable improved vaccination coverage. In this study, solid metal microneedles coated with influenza virus-like particle (VLP) vaccine were inserted into skin for...

Corrigendum to "Protection against lethal challenge by Ebola virus-like particles produced in insect cells" [Virology 383 (2009) 12-21].

Virology

Sun Y, Carrion R, Ye L, Wen Z, Ro YT, Brasky K, Ticer AE, Schwegler EE, Patterson JL, Compans RW, Yang C.
PMID: 30208511
Virology. 2010 Mar 30;399(1):186. doi: 10.1016/j.virol.2009.10.037. Epub 2010 Jan 25.

No abstract available.

Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.

Vaccines

Gangadhara S, Kwon YM, Jeeva S, Quan FS, Wang B, Moss B, Compans RW, Amara RR, Jabbar MA, Kang SM.
PMID: 29257056
Vaccines (Basel). 2017 Dec 19;5(4). doi: 10.3390/vaccines5040052.

Heterologous prime boost with DNA and recombinant modified vaccinia virus Ankara (rMVA) vaccines is considered as a promising vaccination approach against human immunodeficiency virus (HIV-1). To further enhance the efficacy of DNA-rMVA vaccination, we investigated humoral and cellular immune...

Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.

Virology

Menne Z, Pliasas VC, Compans RW, Glover S, Kyriakis CS, Skountzou I.
PMID: 34375782
Virology. 2021 Oct;562:197-208. doi: 10.1016/j.virol.2021.08.001. Epub 2021 Aug 05.

Neuraminidase (NA) is the second most abundant glycoprotein on the surface of influenza A viruses (IAV). Neuraminidase type 1 (NA1) based virus-like particles (VLPs) have previously been shown to protect against challenge with H1N1 and H3N2 IAV. In this...

Structural domains in vesicular stomatitis virus membrane as studied by differential scanning calorimetry.

Biophysical journal

Brouillette CG, Compans RW, Segrest JP, Brandts JF.
PMID: 19431481
Biophys J. 1982 Jan;37(1):25-6. doi: 10.1016/S0006-3495(82)84581-5.

No abstract available.

["School health education. Its consequences in the families"].

Acta pediatrica espanola

Ruiz Santamaria JA, Company R.
PMID: 5860089
Acta Pediatr Esp. 1965 Dec;23(276):1243-8.

No abstract available.

Correction: Pre-post synaptic alignment through neuroligin-1 tunes synaptic transmission efficiency.

eLife

Haas KT, Compans B, Letellier M, Bartol TM, Grillo-Bosch D, Sejnowski TJ, Sainlos M, Choquet D, Thoumine O, Hosy E.
PMID: 33325824
Elife. 2020 Dec 16;9. doi: 10.7554/eLife.65689.

No abstract available.

Co-Delivery of M2e Virus-Like Particles with Influenza Split Vaccine to the Skin Using Microneedles Enhances the Efficacy of Cross Protection.

Pharmaceutics

Kim MC, Kim KH, Lee JW, Lee YN, Choi HJ, Jung YJ, Kim YJ, Compans RW, Prausnitz MR, Kang SM.
PMID: 31003421
Pharmaceutics. 2019 Apr 18;11(4). doi: 10.3390/pharmaceutics11040188.

It is a high priority to develop a simple and effective delivery method for a cross-protective influenza vaccine. We investigated skin immunization by microneedle (MN) patch with human influenza split vaccine and virus-like particles containing heterologous M2 extracellular (M2e)...

Structural proteins of Tacaribe and Tamiami virions.

Virology

Card GP, Vezza AC, Bishop DH, Compans RW.
PMID: 18625477
Virology. 1977 Nov;83(1):84-95. doi: 10.1016/0042-6822(77)90212-4.

Tacaribe and Tamiami viruses were grown in BHK-21 monolayers and purified by centrifugation in combination glycerol-tartrate gradients followed by sucrose gradient centrifugation. The major polypeptides of Tacaribe and Tamiami virions were shown to differ from those of Pichinde virions...

Membrane Glycoproteins of Enveloped Viruses.

Current topics in membranes and transport

Compans RW, Kemp MC.
PMID: 32287477
Curr Top Membr Transp. 1978;11:233-277. doi: 10.1016/S0070-2161(08)60750-9. Epub 2008 May 30.

This chapter focuses on the recent information of the glycoprotein components of enveloped viruses and points out specific findings on viral envelopes. Although enveloped viruses of different major groups vary in size and shape, as well as in the...

Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.

Virology

Menne Z, Pliasas VC, Compans RW, Glover S, Kyriakis CS, Skountzou I.
PMID: 34375782
Virology. 2021 Oct;562:197-208. doi: 10.1016/j.virol.2021.08.001. Epub 2021 Aug 05.

Neuraminidase (NA) is the second most abundant glycoprotein on the surface of influenza A viruses (IAV). Neuraminidase type 1 (NA1) based virus-like particles (VLPs) have previously been shown to protect against challenge with H1N1 and H3N2 IAV. In this...

Showing 1 to 12 of 17 entries